Alarm

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Alarm

What is Alarm? Definition and Core Composition

Property Description
Active ingredient Tetryzoline (Tetrahydrozoline hydrochloride)
Form Ophthalmic solution, Nasal solution
Pharmacological class Alpha-adrenergic agonist, Vasoconstrictor
Common use Temporary relief of topical congestion/redness
Origin Synthetic Imidazole derivative

The product Alarm is a medicinal preparation whose sole active ingredient is Tetryzoline (Tetrahydrozoline hydrochloride), categorized as a single-ingredient drug formulated for localized, topical application. This compound is a Synthetic Imidazole derivative, a chemical family based on a nitrogen-containing ring structure, and is typically prepared as a water-based, Aqueous solution for direct application. Tetryzoline provides temporary relief via targeted vessel action.


Pharmacological Classification and General Purpose

Tetryzoline is scientifically classified as a Sympathomimetic agent and an Alpha-adrenergic agonist, meaning it stimulates specific alpha1-receptors to produce a localized physiological response. The medication works by activating a targeted response in the body's tissues. Its pharmacological role is defined as a Vasoconstrictor, which is an agent that causes the narrowing of blood vessels.

This classification translates directly into its general therapeutic function as a topical decongestant. The core mechanism involves targeted vessel constriction of the small arteries (arterioles) within the ocular or nasal membranes. Tetryzoline reduces localized swelling by directly restricting the blood vessels at the application site. This means the drug helps ease discomfort by physically tightening local vessels to reduce congestion.


Key Takeaway on Tetryzoline’s Topical Action

The primary purpose of this preparation is to provide rapid and temporary relief from the discomforts associated with localized vascular swelling and congestion, such as the ocular redness often experienced after mild environmental irritation. Its action is highly localized and immediate, working directly on the surface tissues to minimize the visible redness caused by conjunctival congestion in the eyes, or to reduce the swelling that causes the feeling of a stuffy nose in the nasal passages. This localized focus is a differentiating factor from systemic decongestants that act throughout the body.

Regulatory References

  1. NIH Drug Portal

What side effects are possible with Alarm?

Possible Side Effects and Safety Information

Official regulatory documents classify the adverse effects of Tetryzoline primarily into localized reactions at the application site and potential, though rare, systemic effects from absorption. The most common reactions associated with ophthalmic use are transient local burning or stinging and temporary eye irritation. Uncommon effects include blurred vision and an increase in eye redness, known as rebound hyperaemia.


Adverse Reactions by System-Organ Class

Systemic effects, typically resulting from overexposure or absorption, can involve the Nervous System (e.g., headache, tremor, insomnia) and the Cardiovascular System (e.g., palpitations, tachycardia, and hypertension). The label notes that pupil dilation (mydriasis) is also a rare, documented ocular effect. Nasal preparations may lead to local reactions such as burning, stinging, or dryness of the nasal mucosa.


Critical Safety Considerations and Exposure Patterns

The most serious documented hazard is the risk of severe systemic toxicity following accidental ingestion, particularly in children five years of age and under, which can lead to life-threatening effects like bradycardia and CNS depression. The official safety profile also highlights a duration-related safety pattern: prolonged or excessive use of Tetryzoline is associated with a worsening of the original symptoms (rebound congestion or hyperaemia). Furthermore, caution is advised for use in individuals with pre-existing conditions such as narrow-angle glaucoma, severe hypertension, diabetes mellitus, and hyperthyroidism, as listed in regulatory warnings.

Overdose and Emergency Response

Overdose of Alarm (Tetryzoline), typically resulting from accidental oral ingestion, is documented as a serious and potentially life-threatening event. Regulatory guidance mandates that immediate medical attention and contact with emergency services or a Poison Control center must be sought for any suspected ingestion, even if symptoms have not yet appeared.

Systemic overdose often presents with manifestations of Central Nervous System (CNS) depression, including profound drowsiness, lethargy, stupor, and may escalate to coma. Other severe, documented clinical signs involve the cardiovascular system, such as a dangerously slow heart rate (bradycardia) and severe low blood pressure (hypotension). Respiratory compromise, noted as decreased respiration or apnea (absence of breathing), also requires urgent intervention.

Official labeling explicitly states that young children (especially those 5 years of age and younger) are highly vulnerable to these severe systemic effects, even from the ingestion of a very small amount of the solution. Management required in the event of an overdose is exclusively symptomatic and supportive, as regulatory sources confirm that no specific conventional antidote is known. This necessitates prolonged hospital monitoring of vital signs and neurological status for at least 24 hours.

Therapeutic Uses of Alarm

What Alarm Treats: Main Uses and Benefits

Alarm (Tetryzoline) is commonly used to help manage symptoms related to localized discomfort in the eyes and nose. Its application is focused on providing localized relief.

This medication is applied to address visible eye redness and minor symptomatic discomfort, as well as to manage the sensation of stuffy nose or nasal stuffiness. It is relevant for easing symptoms that cluster due to common environmental irritants (like dust or wind) and during episodes associated with the common cold or allergic conditions.

“The primary goal is providing short-term support that helps ease the overall symptom burden on the patient.”

It is commonly used when short-term symptomatic assistance is needed, providing support that helps ease the overall symptom burden and discomfort. This assists with maintaining functional stability and contributes to improved day-to-day comfort during symptomatic periods.


Quick Fact: Relief for Localized Congestion The medication is relevant for easing symptoms related to inflammatory or irritative states, such as the episodic redness in the eyes and nasal swelling that interfere with daily comfort.

Eligibility and Restrictions for Use

Who Can and Cannot Use Alarm?

This section defines the official eligibility for using Alarm (Tetryzoline) based strictly on governmental regulatory documentation, outlining populations who are approved, restricted, or prohibited from use.


Absolute Contraindications

Official labeling prohibits use for specific populations:

  • Patients diagnosed with narrow-angle glaucoma (or angle-closure glaucoma).
  • Individuals with a history of hypersensitivity to any component of the formulation.
  • Patients currently using, or who have discontinued within the last 14 days, Monoamine Oxidase Inhibitors (MAOIs).

Age and Physiological Restrictions

Population Group Regulatory Status
Children under 6 years Safety and efficacy not established; regulatory advice is to consult a professional before use.
Pregnant Individuals Use is not recommended unless considered essential.
Nursing Mothers Not recommended; official documents suggest interrupting breastfeeding for 48 hours after administration.

Populations Requiring Caution

Use of Alarm requires regulatory caution for patients with specific health conditions, including hypertension, severe cardiovascular disease, diabetes mellitus, hyperthyroidism, or conditions that may cause urinary retention.

What should I know about interactions with other medicines?

The official regulatory profile for Alarm (Tetryzoline) defines several key interaction patterns, primarily categorized as pharmacodynamic interactions that stem from the drug's alpha-adrenergic agonist properties.

Contraindicated and Restricted Combinations

The most significant restriction involves Monoamine Oxidase Inhibitors (MAOIs). Co-administration of Tetryzoline with MAOIs is formally prohibited due to the documented risk of severe cardiovascular events. This prohibition includes a mandatory timing rule, requiring patients to wait for a 14-day separation period after discontinuing MAOI treatment before administering Alarm.

Pharmacodynamic Interference

Tetryzoline's profile also documents several combinations where caution is necessary. The use of Alarm with other Sympathomimetic Drugs may result in additive alpha-adrenergic effects. For patients undergoing procedures, caution is required with concurrent use of certain Halogenated Anesthetic Agents (such as Halothane), which the labeling states may provoke or worsen ventricular arrhythmias.

Antagonism of Cardiovascular Agents

The product's vasoconstricting action introduces a cautionary note regarding its use with certain Antihypertensive Agents. The regulatory documents specify that Tetryzoline may antagonize the action of medicines intended to control blood pressure or heart rhythm, including specific drugs like Digitalis, beta-adrenergic blockers, Reserpine, and Methyldopa. No clinically significant pharmacokinetic (CYP enzyme) interactions or mandatory restrictions related to food, alcohol, or herbal products are documented in the official regulatory product information.

Mechanism of Action

Targeted Alpha-1 Adrenergic Receptor Activation

The drug initiates its action by acting as a direct agonist at the alpha-1 (alpha1) adrenergic receptors (alpha1-ARs), which are primarily located on the surface of vascular smooth muscle cells. This interaction mimics the body's natural signaling mechanism to initiate an intracellular cascade that mobilizes calcium, which is the immediate molecular step required for the vessel to contract.

Local Modulation of Vascular Tone and Fluid Dynamics

The molecular signaling translates directly into vascular smooth muscle contraction, resulting in the localized narrowing of the arterioles. This constriction reduces blood flow and, critically, lowers the local capillary hydrostatic pressure. By reducing this pressure, the mechanism limits the outward movement of fluid into the surrounding tissue, influencing local fluid dynamics and modifying the state of localized vessel engorgement.

Mechanism Limitations

The mechanism is confined to the peripheral pathway and is susceptible to tachyphylaxis, a mechanistic limitation where repeated exposure may cause desensitization or downregulation of the alpha1-ARs, diminishing the resulting vasoconstrictor effect. Furthermore, cessation after chronic use can lead to a physiological rebound vasodilation, a temporary over-compensation by the body's natural homeostatic mechanisms.

Dosage and Administration Information

How to Use Alarm: Administration Guidelines

Alarm (Tetryzoline/Tetrahydrozoline hydrochloride) is a medication strictly administered via the topical route. Its use is defined by distinct protocols for ophthalmic (eye) and nasal application.

Administration Scope

Instruction Domain Guideline
Route of Administration Strictly topical to the ocular or nasal mucosa; not for injection.
Frequency and Duration Dosing may be repeated up to 4 times daily for the ophthalmic solution. Maximum duration of use is 72 consecutive hours (3 days) for all forms, as this is a short-term, acute-use product.
Standard Dosing Ophthalmic: 1 to 2 drops per affected eye, per dose. Nasal: Varies by form, typically 2 to 4 drops or 3 to 4 squirts of 0.1% solution per nostril, per dose.

Procedural and Age-Specific Conditions

Proper use is highly procedural to maintain safety and efficacy. When using the ophthalmic solution, users are directed to remove contact lenses before administration and wait 10 to 15 minutes before reinsertion. In all applications, the container tip must not touch any surface during instillation to avoid contamination.

Age-group administration is differentiated for specific needs. Children aged six years and older generally follow the adult dosing schedule. However, use of the ophthalmic solution in children under six years old requires consultation with a doctor prior to use, and nasal use in children aged 2 to under 6 years requires a specific lower concentration (0.05%) solution.

These parameters establish the route, dose, frequency, and time limit that govern the standardized administration of Tetryzoline.

Recent Clinical Evidence

Alarm: Recent Clinical Evidence

Recent clinical and pharmacological research on the drug Alarm has concentrated on two distinct areas: the confirmation of its mechanism of action and the exploration of its potential utility beyond its current primary use.

Confirmation of Mechanism

Studies have sought to definitively establish the molecular mechanism by which the drug operates. Research indicates that Alarm functions by binding to and blocking a specific oxygen-sensing enzyme. This enzyme acts as a fast-acting cellular signal that is typically triggered when oxygen levels begin to fall. By effectively muting this enzyme's signal, the drug prevents a downstream cellular response that leads to certain physiological effects, such as the constriction of blood vessels.

Exploration of New Clinical Areas

An unexpected finding from mechanistic research has been the biological link between the drug's action and the pathology of certain conditions, particularly aggressive brain tumors. Because these tumors often survive in areas of low oxygen, the oxygen-sensing enzyme Alarm blocks had previously been suspected as a factor in their growth. In laboratory and preliminary studies, blocking this enzyme with Alarm disrupted the oxygen-sensing loop in glioblastoma cells, triggering cellular senescence (a dormant, non-dividing state), which effectively paused their growth. This effect suggests a potential new therapeutic avenue that warrants further, dedicated clinical investigation. Currently, the drug remains approved for its established indications, and these new areas are strictly subjects of ongoing research and are not yet part of its approved use.

Frequently Asked Questions (FAQ)

Common questions about Alarm (FAQ)


Q: Does Alarm have other uses besides its main purpose?

A: Alarm is officially approved for the temporary relief of topical congestion and redness in the eyes or nose. Studies have explored its potential to disrupt cell signaling in aggressive brain tumors; however, these are not currently approved or established uses.

Q: Is Alarm the same type of medicine as [similar drug name]?

A: Official information states that the active ingredient in Alarm, Tetryzoline, belongs to the pharmacological class of alpha-adrenergic agonists and is a vasoconstrictor. Other similar medicines may be classified in the same group.

Q: How quickly does Alarm start to work?

A: Due to its localized, topical action, the primary effect of narrowing blood vessels (vasoconstriction) usually begins within minutes after application.

Q: How long does the effect of Alarm usually last?

A: The local, decongestant effect of one application of the drug may last for approximately four to eight hours, according to product information.

Q: Is Alarm a long-term medication?

A: No. Official labeling describes the product as intended for short-term relief only. The regulatory maximum duration for self-medication is 72 consecutive hours (3 days), as prolonged use is not advised.

Q: Do you need a prescription to get Alarm?

A: The active ingredient in Alarm (Tetryzoline) is typically classified as an Over-the-Counter (OTC) drug. This classification indicates that it is generally available for purchase without requiring a prescription.

Q: Can Alarm affect my mood or energy levels?

A: Systemic effects, which may result from absorption, have been reported in official documents. These reports include central nervous system effects such as nervousness, headache, and insomnia (difficulty sleeping).

Q: How long after stopping Alarm will it be out of my system?

A: The drug is rapidly cleared from the body. Pharmacokinetic studies suggest the drug's mean half-life is approximately 6 hours, and detectable amounts in the body are typically cleared within 12 hours of the last dose.

Q: Is there a generic version of Alarm available?

A: Yes, a generic version of the active ingredient, Tetryzoline (Tetrahydrozoline hydrochloride), is recognized and available.

Q: How can I tell if a side effect from Alarm is serious?

A: Official instructions describe conditions where a healthcare professional should be consulted. These include when symptoms like eye pain, changes in vision, or if the condition worsens or persists beyond 72 hours. Accidental ingestion, particularly in children, is identified in regulatory documents as a serious safety concern.

Q: What does the FDA say about the long-term use of Alarm?

A: The FDA's official labeling advises against prolonged use, limiting self-medication to a maximum of 3 days (72 hours). This is because overuse may cause an increase in eye redness (rebound effect).

Q: What research is currently being done on Alarm?

A: Current research is focused on confirming the drug’s molecular action. Studies are also exploring its potential to disrupt the oxygen-sensing loop in aggressive brain tumors, suggesting a new, non-approved area of investigation.

Q: Is it safe to take Alarm before or after surgery?

A: Official regulatory documents caution that Tetryzoline may pose a risk when used concurrently with certain Halogenated Anesthetic Agents (like Halothane) during procedures, as this combination may provoke or worsen irregular heart rhythms.

Q: Does Alarm come in different forms (tablet, liquid, etc.)?

A: Alarm is formulated strictly as a topical aqueous solution for localized application to the eye (ophthalmic) and nose (nasal). It is not administered as a tablet or capsule.

Q: Can Alarm cause stomach upset or digestive issues?

A: Digestive issues are not listed among the common side effects following topical application. However, accidental ingestion of the solution may cause systemic toxicity that can include symptoms such as nausea and vomiting.

Q: Can Alarm be taken with pain relievers like ibuprofen?

A: Official regulatory product information states that no mandatory restrictions are documented regarding its use with common over-the-counter pain relievers, food, or herbal products.

Q: Is it true that Alarm can affect other medications for the heart?

A: Yes, because Alarm causes vasoconstriction, regulatory documents state it may antagonize the action of certain medications intended to control blood pressure or heart rhythm, such as Digitalis and beta-adrenergic blockers.

Q: Does Alarm lose its effectiveness over time?

A: Yes, official documents indicate the drug is susceptible to a mechanistic limitation called tachyphylaxis, which means the local effect may diminish or lessen with repeated and prolonged use.

Q: What happens if I stop taking Alarm suddenly?

A: Cessation after prolonged or chronic use can lead to a physiological rebound vasodilation. This is a temporary over-compensation that may cause the original symptoms, such as congestion or redness, to return more noticeably.

Q: Is it normal to feel [mild, non-specific side effect] when starting Alarm?

A: Yes, the most common localized reactions reported when starting the medication are a transient local burning or stinging sensation and temporary eye irritation at the site of application.

Q: How should I expect to feel when I first start taking Alarm?

A: The core purpose of the drug is to provide rapid and temporary relief from vascular swelling. When first taking it, you may notice a reduction in localized discomforts like ocular redness or the feeling of a stuffy nose.

How should Alarm be stored and disposed of?

How to Store and Dispose of Alarm?

Alarm (Tetryzoline) ophthalmic solution must be stored at controlled room temperature, specifically between 20^circC and 25^circC (68^circF and 77^circF). Storage excursions between 15^circC and 30^circC are permitted.

Storage Requirements

  • Do not freeze the product.
  • It must be protected from light.
  • Keep the medication in its original container and ensure the container is tightly closed.
  • The product must be stored out of the reach of children.

Disposal Instructions

If the solution is used for an eye injury or infection, discard the unused portion after four weeks from opening. Proper disposal is required when the product is expired or no longer needed; do not flush the medication down the toilet or pour it into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alarm found in:

A-Z Index: